Adverse Drug Events Associated with Low-Dose (10 mg) Versus High-Dose (25 mg) Empagliflozin in Patients Treated for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Crossref DOI link: https://doi.org/10.1007/s13300-018-0399-z
Published Online: 2018-03-09
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dai, Xia
Luo, Zu-chun
Zhai, Lu
Zhao, Wen-piao
Huang, Feng http://orcid.org/0000-0002-3269-7530
Text and Data Mining valid from 2018-03-09
Article History
Received: 30 January 2018
First Online: 9 March 2018